Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Multi-domain prognostic models used in middle-aged adults without known cognitive impairment for predicting subsequent dementia 2023-06-02
  2. Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice? 2010-08-26

Studies

2 studies carry this tag.

Date range

2010 to 2023

Top journals

  • Alzheimer's research & therapy 1
  • The Cochrane database of systematic reviews 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Multi-domain prognostic models used in middle-aged adults without known cognitive impairment for predicting subsequent dementia

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. The Cochrane database of systematic reviews 2023-06-02 Risk factors

    Our secondary objectives were to summarise the prognostic models, to appraise their predictive accuracy (discrimination and calibration) as reported in the development and validation studies, and to identify the implications of using dementia prognostic models for the management of people at a higher risk for future dementia.

  2. Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice?

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Alzheimer's research & therapy 2010-08-26 Prevention trials

    Despite the multitude of AD scales for various purposes, there remains a need for a new multi-domain and easy to administer AD scale for assessment of disease progression and response to therapy in daily medical practice.

All topic tags with their study counts